Caption Management’s AtriCure ATRC Stock Holding History

Caption Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-270	Closed	-$6.15K	–	1268
2024 Q2	$6.15K	Buy	+270	New	+$6.23K	﹤0.01%	1098
2023 Q1	–	Sell	-6,200	Closed	-$275K	–	1081
2022 Q4	$275K	Buy	+6,200	New	+$259K	﹤0.01%	1018
2021 Q4	–	Sell	-700	Closed	-$49K	–	1588
2021 Q3	$49K	Buy	+700	New	+$53.9K	﹤0.01%	1436

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Caption Management's ATRC Position: Q3 2024 in Review

Caption Management sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 270 shares — an estimated $6.15K sold.

Caption Management first reported a position in ATRC in Q3 2021 and held it in 3 quarters. The position peaked at $275K in Q4 2022. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

Caption Management reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
Caption Management sold 270 AtriCure shares in Q3 2024, an estimated $6.15K.
Caption Management first reported a position in AtriCure in Q3 2021 and held it in 3 quarters.
Caption Management's AtriCure position peaked at $275K in Q4 2022.
201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.